
|Articles|December 1, 2002
LASIK advancement: Alcon gets FDA approval for LADARVision system
Hunenberg, Switzerland-The FDA has approved Alcon Inc.'s LADARVision System for customized wavefront-guided laser eye surgery in the treatment of myopia.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
FDA approvals in 2025: What changed and why it matters for ophthalmologists
3
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
4
What changed in glaucoma care in 2025: Surgeon perspective
5












































